| Diane Treadwell-deering, MD | |
|
1600 Rockland Rd, Wilmington, DE 19803-3607 | |
| (302) 651-4200 | |
| Not Available |
| Full Name | Diane Treadwell-deering |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1600 Rockland Rd, Wilmington, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093895336 | NPI | - | NPPES |
| 138930611 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | G0214 (Texas) | Primary |
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
David Lerman, a Berkeley, Calif., lawyer, changed health plans this year only to learn that his new insurer has no contract with the dominant medical provider in his community.
Johns Hopkins researchers report they have figured out how the aptly named protein Botch blocks the signaling protein called Notch, which helps regulate development. In a report on the discovery, to appear online April 24 in the journal Cell Reports, the scientists say they expect the work to lead to a better understanding of how a single protein, Notch, directs actions needed for the healthy development of organs as diverse as brains and kidneys.
Cyberbullying is drawing increasing attention, with online activity soaring and a larger number of bullying cases resulting in tragedy. "Bystander Intervention in Cyberbullying" a new study published in the National Communication Association's Communication Monographs reveals specific online conditions under which witnesses to cyberbullying are likely (or unlikely) to intervene in defense of a victim.
A new national survey of pediatricians and family physicians examines and compares how providers are recommending and communicating about human papillomavirus vaccine, their current delivery practices, reported refusal/deferral rates and associated factors, and perceived barriers to vaccination.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diane Treadwell-deering, MD Po Box 191, Wilmington, DE 19899-0191 Ph: () - | Diane Treadwell-deering, MD 1600 Rockland Rd, Wilmington, DE 19803-3607 Ph: (302) 651-4200 |
News Archive
David Lerman, a Berkeley, Calif., lawyer, changed health plans this year only to learn that his new insurer has no contract with the dominant medical provider in his community.
Johns Hopkins researchers report they have figured out how the aptly named protein Botch blocks the signaling protein called Notch, which helps regulate development. In a report on the discovery, to appear online April 24 in the journal Cell Reports, the scientists say they expect the work to lead to a better understanding of how a single protein, Notch, directs actions needed for the healthy development of organs as diverse as brains and kidneys.
Cyberbullying is drawing increasing attention, with online activity soaring and a larger number of bullying cases resulting in tragedy. "Bystander Intervention in Cyberbullying" a new study published in the National Communication Association's Communication Monographs reveals specific online conditions under which witnesses to cyberbullying are likely (or unlikely) to intervene in defense of a victim.
A new national survey of pediatricians and family physicians examines and compares how providers are recommending and communicating about human papillomavirus vaccine, their current delivery practices, reported refusal/deferral rates and associated factors, and perceived barriers to vaccination.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
› Verified 9 days ago
Dr. Ranganathan Ram, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 410 Foulk Rd Ste 106, Wilmington, DE 19803 Phone: 302-762-2285 Fax: 302-762-2286 | |
Navjot Hanspal, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-2511 Fax: 302-633-5582 | |
Dr. Catherine F. Bodak-gyovai, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-5967 | |
Dr. Subani Maheshwari, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 W 14th Street, 1st Floor, Suite 1e40, Wilmington, DE 19801 Phone: 302-320-2100 Fax: 302-320-2121 | |
Dr. Dyanne Simpson, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W 10th Street, Wilmington, DE 19801 Phone: 302-230-9154 Fax: 302-691-1100 | |
Dr. Troy L. Thompson Ii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W 10th Street, Wilmington, DE 19801 Phone: 302-230-9192 Fax: 302-691-1100 | |
Carol Tavani, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 West 14th Street, 3rd Floor, Wilmington, DE 19801 Phone: 302-428-2100 Fax: 302-428-2121 |